Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer

BACKGROUND: Despite the preclinical outcomes and biologic significance of the presence of the human epidermal growth factor receptor-2 (HER2) extracellular domain (ECD), there is little evidence supporting the measurement of ECD levels in any clinical setting. The aim of this study was to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sae Byul, Lee, Jong Won, Yu, Jong Han, Ko, Beom Seok, Kim, Hee Jeong, Son, Byung Ho, Gong, Gyungyub, Lee, Hee Jin, Kim, Sung-Bae, Jung, Kyung Hae, Ahn, Jin-Hee, Lee, Woochang, Sung, Joohon, Ahn, Sei-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295268/
https://www.ncbi.nlm.nih.gov/pubmed/25491647
http://dx.doi.org/10.1186/1471-2407-14-929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295268/
https://www.ncbi.nlm.nih.gov/pubmed/25491647
http://dx.doi.org/10.1186/1471-2407-14-929

Ejemplares similares